A deep learning algorithm to predict coexisting metastatic disease using intraprostatic [F18]DCFPYL PSMA image alone in veterans with prostate cancer.

2020 ◽  
Vol 38 (6_suppl) ◽  
pp. 25-25
Author(s):  
Nicholas George Nickols ◽  
Aseem Anand ◽  
Karl Sjöstrand ◽  
Lida Jafari ◽  
John Ceccoli ◽  
...  

25 Background: [F18]DCFPyL (PyL) is a PSMA targeted imaging agent for prostate cancer. Independent of manual feature selection, a deep learning algorithm might offer additional insight into the disease biology. We explored the performance of a deep learning algorithm on PyL images of the primary tumor to predict co-existing distant metastases. Methods: 74 veterans with high risk primary prostate cancer tumors were imaged with both PyL PSMA PET/CT and conventional imaging (bone scan and CT or MRI of the abdomen/pelvis). 26% were confirmed with metastatic disease (M1) by conventional imaging. The PyL images of the primary tumor were analyzed with EXINI’s PyL-AI algorithm. Location of the prostate was defined on low dose CT via automatic segmentation using a deep convolutional network. The segmentations were used to map the PyL PET image of the prostate. The image based PyL-AI model was made up of a Conv3D layer of 4 kernels, a Conv3D layer of 8 kernels, a dense layer of 64 nodes followed by a final dense layer with 2 nodes. The model training was performed on the images using 5-fold cross validation with non-overlapping validation sets. The test predictions were compared with ground truth (M1); the area under ROC curve (AUC) was computed to determine the performance of the model in predicting the presence of distant metastases. A logistical regression model from baseline clinicopathologic features of the primary tumor (baseline PSA, biopsy gleason score, percent cores positive, T stage) was created as a comparator. Results: The logistical regression model using clinicopathologic features had an AUC of 0.71, while the PyL-AI model based on intra-prostatic PyL Images alone had an AUC of 0.81 for prediction of metastatic disease as defined by conventional imaging. Adding clinical parameters in the image based PyL-AI model incrementally increased the AUC to 0.82. Conclusions: The image based PyL-AI deep learning model demonstrates a higher predictive accuracy over the logistic model using classical clinicopathologic features. The study is hypothesis generating observation that needs prospective validation in an independent data set.

2019 ◽  
Vol 2 (1) ◽  
Author(s):  
Kunal Nagpal ◽  
Davis Foote ◽  
Yun Liu ◽  
Po-Hsuan Cameron Chen ◽  
Ellery Wulczyn ◽  
...  

JAMA Oncology ◽  
2020 ◽  
Vol 6 (9) ◽  
pp. 1372 ◽  
Author(s):  
Kunal Nagpal ◽  
Davis Foote ◽  
Fraser Tan ◽  
Yun Liu ◽  
Po-Hsuan Cameron Chen ◽  
...  

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e16572-e16572
Author(s):  
Alexa Meyer ◽  
Nancy Stambler ◽  
Karl Sjöstrand ◽  
Jens Richter ◽  
Mohamad Allaf ◽  
...  

e16572 Background: Previous work has shown that the degree of expression of prostate-specific membrane antigen (PSMA) correlates with prostate cancer (PCa) grade and stage. We evaluated the additive value of a deep learning algorithm (PSMA-AI) of a PSMA-targeted small molecule SPECT/CT imaging agent (99mTc-MIP-1404) to identify men with low risk PCa who are potential active surveillance candidates. Methods: A secondary analysis of a phase III trial (NCT02615067) of men with PCa who underwent 99mTc-MIP-1404 SPECT/CT was conducted. Patients with a biopsy Gleason score (GS) of ≤6, clinical stage ≤T2, and prostate specific antigen (PSA) < 10 ng/mL who underwent radical prostatectomy (RP) following SPECT/CT were included in the present analysis. SPECT/CT images were retrospectively analyzed by PSMA-AI, which was developed and locked prior to analysis. PSMA-AI calculated the uptake of 99mTc-MIP-1404 against the background reference (TBR). The automated TBR of 14 was used as a threshold for PSMA-AI calls of positive disease. Multivariable logistic regression analysis was used to develop a base model for identifying men with occult GS ≥7 PCa in the RP specimen. This model included PSA density, % positive biopsy cores, and clinical stage. The diagnostic performance of this model was then compared to a second model that incorporated PSMA-AI calls. Results: In total, 87 patients enrolled in the original trial contributed to the analysis. The base model indicated that PSA density and % positive cores were significantly associated with occult GS ≥7 PCa (p < 0.05), but clinical stage was not (p = 0.23). The predictive ability of the model resulted in an area under the curve (AUC) of 0.73. Upon adding PSMA-AI calls, the AUC increased to 0.77. PSMA-AI calls (p = 0.045), pre-surgery PSA density (0.019) and % positive core (p < 0.004) remained statistically significant. PSMA-AI calls increased the positive predictive value from 70% to 77% and the negative predictive value from 57% to 74%. Conclusions: The addition of PSMA-AI calls demonstrated a significant improvement over known predictors for identifying men with occult GS ≥7 PCa, who are inappropriate candidates for active surveillance. Clinical trial information: NCT02615067.


2021 ◽  
Vol 46 (2) ◽  
pp. 80
Author(s):  
Prabhakar Ramachandran ◽  
Keya Amarsee ◽  
Andrew Fielding ◽  
Margot Lehman ◽  
Christopher Noble ◽  
...  

2019 ◽  
Vol 2 (1) ◽  
Author(s):  
Kunal Nagpal ◽  
Davis Foote ◽  
Yun Liu ◽  
Po-Hsuan Cameron Chen ◽  
Ellery Wulczyn ◽  
...  

An amendment to this paper has been published and can be accessed via a link at the top of the paper.


Sign in / Sign up

Export Citation Format

Share Document